The heads of the Food and Drug Administration (FDA) and the National Institutes of Health (NIH) coauthored a new letter describing that status of research into psychedelic drugs such as psilocybin, LSD and ibogaine. The letter, dated last week, also contains surprising admissions about the therapeutic potential of these federally prohibited controlled substances. It comes … Continue reading Federal Health Agencies Acknowledge Therapeutic Potential Of Psychedelics